In the evolving landscape of Diagnostic Imaging space, the report on the Contrast Media Injectors Market captures vital strategic insights, exploring derivative market segments, volumes, and forecasts up till 2033. These injectors, whether manual, automatic, syringeless, dual or single-headed, enhance image quality in CT and MRI scans by clarifying hard-to-image internal structures within the human anatomy.
Growth in the sales of diagnostic imaging systems, such as MRI and CT scanners, drives the demand for contrast media injectors. This is a response to the aging global populations and rising chronic diseases. With economic expansion in emerging countries like India and China, the market is experiencing high growth.
By incorporating qualitative and quantitative trends, this model provides a holistic view of the Contrast Media Injectors market. It further offers an overview of the healthcare system along with details on medtech regulatory landscape and reimbursement policies for each of the 39 countries covered. Unique country-specific insights, SWOT analyses, competitive dynamics, and Key Opinion Leaders (KOL)'s views make this report a must-have for executives, investors and stakeholders seeking to make informed strategic decisions.
The model discusses in detail the impact of COVID-19 on Contrast Media Injectors market for the year 2020 and beyond. Contrast media injectors can be categorized as manual, automatic, syringeless, dual or single headed. Contrast media injectors are the key devices for improving image quality in various CT and MRI scanning procedures by delivering the contrast media to clarify hard to image structures within the body such as blood vessels.
The market for contrast media injectors is driven by sales of diagnostic imaging systems such as MRI and CT scanners, which have been experiencing growth due to aging global populations and the rising prevalence of chronic diseases. The market for contrast media injectors is experiencing stable growth globally and high growth in emerging economies like China and India whose health sectors are booming.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Contrast Media Injectors and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total Contrast Media Injectors market revenue by segment and market outlooks from 2015-2033.
- Market level data on units, average selling prices and market values.
Global, Regional and Country level market specific insights:
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition publisher analysts provide unique country specific insights on the market.
- SWOT analysis for Contrast Media Injectors market.
- Competitive dynamics insights and trends provided for Contrast Media Injectors market.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Companies covered: Imaxeon Pty Ltd, Nemoto Kyorindo Co Ltd, Guerbet SA, Bracco Imaging SpA, Ulrich GmbH & Co KG, Sino Medical-Device Technology Co., Ltd., and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
- CMO executives who must have deep understanding of the Contrast Media Injectors marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to:
- Understand the impact of COVID-19 on Contrast Media Injectors market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving Contrast Media Injectors market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Contrast Media Injectors market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Contrast Media Injectors market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
A selection of companies mentioned in this report includes:
- Imaxeon Pty Ltd
- Nemoto Kyorindo Co Ltd
- Guerbet SA
- Bracco Imaging SpA
- Ulrich GmbH & Co KG
- Sino Medical-Device Technology Co., Ltd.